Загрузка...
CD19 CAR-T细胞治疗B细胞淋巴瘤22例疗效及安全性
OBJECTIVE: To investigate the efficacy and safety of CD19 chimeric antigen receptor T (CAR-T) lymphocytes for the treatment of B cell lymphoma. METHODS: A total of 22 patients with B-cell lymphoma from February 1, 2017 to July 1, 2018 were reviewed to evaluate the efficacy and adverse reactions of C...
Сохранить в:
| Опубликовано в: : | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Editorial office of Chinese Journal of Hematology
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7343005/ https://ncbi.nlm.nih.gov/pubmed/31104437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.04.003 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|